Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study.

Millán Núñez-Cortés J, Cases Amenós A, Ascaso Gimilio JF, Barrios Alonso V, Pascual Fuster V, Pedro-Botet Montoya JC, Pintó Sala X, Serrano Cumplido A.

Am J Cardiovasc Drugs. 2017 Apr;17(2):135-142. doi: 10.1007/s40256-016-0197-9.

2.

Pitavastatin improves glycated hemoglobin in patients with poorly controlled type 2 diabetes.

Huang CH, Huang YY, Hsu BR.

J Diabetes Investig. 2016 Sep;7(5):769-76. doi: 10.1111/jdi.12483. Epub 2016 Feb 22.

3.

Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk.

Laufs U, Karmann B, Pittrow D.

Clin Res Cardiol. 2016 Sep;105(9):783-90. doi: 10.1007/s00392-016-0991-z. Epub 2016 Apr 27.

4.

Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association.

Shimada A, Kimura H, Oida K, Kanehara H, Bando Y, Sakamoto S, Wakasugi T, Saga T, Ito Y, Kamiyama K, Mikami D, Iwano M, Hirano T, Yoshida H.

Lipids Health Dis. 2016 Mar 17;15:57. doi: 10.1186/s12944-016-0223-6.

5.

The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin.

Kashi Z, Mahrooz A, Kianmehr A, Alizadeh A.

PLoS One. 2016 Mar 15;11(3):e0151543. doi: 10.1371/journal.pone.0151543. eCollection 2016 Mar 15.

6.

Postprandial Hypertriglyceridemia Predicts Development of Insulin Resistance Glucose Intolerance and Type 2 Diabetes.

Aslam M, Aggarwal S, Sharma KK, Galav V, Madhu SV.

PLoS One. 2016 Jan 25;11(1):e0145730. doi: 10.1371/journal.pone.0145730. eCollection 2016 Jan 25.

7.

Lipoprotein hydrophobic core lipids are partially extruded to surface in smaller HDL: "Herniated" HDL, a common feature in diabetes.

Amigó N, Mallol R, Heras M, Martínez-Hervás S, Blanco Vaca F, Escolà-Gil JC, Plana N, Yanes Ó, Masana L, Correig X.

Sci Rep. 2016 Jan 18;6:19249. doi: 10.1038/srep19249.

8.

Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS).

Livingstone SJ, Looker HC, Akbar T, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Fuller JH, Colhoun HM.

Diabetologia. 2016 Feb;59(2):299-306. doi: 10.1007/s00125-015-3802-6. Epub 2015 Nov 17.

9.

Simvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells.

Yaluri N, Modi S, López Rodríguez M, Stančáková A, Kuusisto J, Kokkola T, Laakso M.

PLoS One. 2015 Nov 11;10(11):e0142902. doi: 10.1371/journal.pone.0142902. eCollection 2015 Nov 11.

10.

Atorvastatin Treatment for Carotid Intima-Media Thickness in Chinese Patients With Type 2 Diabetes: A Meta-Analysis.

Fang N, Han W, Gong D, Zou Chen, Fan Y.

Medicine (Baltimore). 2015 Nov;94(44):e1920. doi: 10.1097/MD.0000000000001920. Review.

12.

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.

Gyberg V, De Bacquer D, De Backer G, Jennings C, Kotseva K, Mellbin L, Schnell O, Tuomilehto J, Wood D, Rydén L, Amouyel P, Bruthans J, Conde AC, Cifkova R, Deckers JW, De Sutter J, Dilic M, Dolzhenko M, Erglis A, Fras Z, Gaita D, Gotcheva N, Goudevenos J, Heuschmann P, Laucevicius A, Lehto S, Lovic D, Miličić D, Moore D, Nicolaides E, Oganov R, Pająk A, Pogosova N, Reiner Z, Stagmo M, Störk S, Tokgözoğlu L, Vulic D; EUROASPIRE Investigators..

Cardiovasc Diabetol. 2015 Oct 1;14:133. doi: 10.1186/s12933-015-0296-y.

13.

Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins.

Sakamoto K, Kawamura M, Kohro T, Omura M, Watanabe T, Ashidate K, Horiuchi T, Hara H, Sekine N, Chin R, Tsujino M, Hiyoshi T, Tagami M, Tanaka A, Mori Y, Inazawa T, Hirano T, Yamazaki T, Shiba T; RESEARCH Study Group..

PLoS One. 2015 Sep 23;10(9):e0138332. doi: 10.1371/journal.pone.0138332. eCollection 2015 Sep 23.

14.

Combining citrulline with atorvastatin preserves glucose homeostasis in a murine model of diet-induced obesity.

Capel F, Chabrier G, Pitois E, Rigaudière JP, Le Plenier S, Durand C, Jouve C, de Bandt JP, Cynober L, Moinard C, Morio B.

Br J Pharmacol. 2015 Oct;172(20):4996-5008. doi: 10.1111/bph.13269. Epub 2015 Oct 13.

15.

Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients.

Apro J, Parini P, Broijersén A, Angelin B, Rudling M.

J Lipid Res. 2015 Aug;56(8):1633-9. doi: 10.1194/jlr.P058842. Epub 2015 Jun 19.

16.

The Effects of Atorvastatin on Arterial Stiffness in Male Patients with Type 2 Diabetes.

Davenport C, Ashley DT, O'Sullivan EP, McHenry CM, Agha A, Thompson CJ, O'Gorman DJ, Smith D.

J Diabetes Res. 2015;2015:846807. doi: 10.1155/2015/846807. Epub 2015 Apr 30.

17.

Urea and protein carbamylation in ESRD: surrogate markers or partners in crime?

Velasquez MT, Ramezani A, Raj DS.

Kidney Int. 2015 Jun;87(6):1092-4. doi: 10.1038/ki.2015.78.

18.

A pilot study of ezetimibe vs. atorvastatin for improving peripheral microvascular endothelial function in stable patients with type 2 diabetes mellitus.

Sugiyama S, Jinnouchi H, Hieshima K, Kurinami N, Suzuki T, Miyamoto F, Kajiwara K, Matsui K, Jinnouchi T.

Lipids Health Dis. 2015 Apr 23;14:37. doi: 10.1186/s12944-015-0028-z.

19.

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial.

Soedamah-Muthu SS, Livingstone SJ, Charlton-Menys V, Betteridge DJ, Hitman GA, Neil HA, Bao W, DeMicco DA, Preston GM, Fuller JH, Stehouwer CD, Schalkwijk CG, Durrington PN, Colhoun HM; CARDS Investigators..

Diabetologia. 2015 Jul;58(7):1494-502. doi: 10.1007/s00125-015-3586-8. Epub 2015 Apr 22.

20.

Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes.

Li L, Zhang M, Su F, Li Y, Shen Y, Shen J, Zhang D.

Lipids Health Dis. 2015 Feb 18;14:10. doi: 10.1186/s12944-015-0004-7.

Supplemental Content

Loading ...
Support Center